星空体育官方入口网站网址大全-登录入口官网

#乙肝患者#

55篇内容 | 1284人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1671785, encodeId=c00d16e1785f0, content=<a href='/topic/show?id=0bcc2342943' target=_blank style='color:#2F92EE;'>#乙肝患者#</a>, objectTitle=Aliment Pharmacol Ther：中心性肥胖的慢性乙肝患者发展成肝癌的风险增加了两倍！, objectType=article, longId=213448, objectId=4a2021344866, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4a2021344866, replyNumber=0, likeNumber=78, createdTime=2021-10-25, rootId=0, userName=sjzlzc016, userId=fc1826842253, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4a2021344866, moduleTitle=Aliment Pharmacol Ther：中心性肥胖的慢性乙肝患者发展成肝癌的风险增加了两倍！, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=4a2021344866)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1671784, encodeId=ec5d16e17843b, content=<a href='/topic/show?id=0bcc2342943' target=_blank style='color:#2F92EE;'>#乙肝患者#</a>, objectTitle=FIB-4指数：可预测慢乙肝患者抗病毒治疗后的肝癌风险, objectType=article, longId=209889, objectId=5a2f2098893d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5a2f2098893d, replyNumber=0, likeNumber=151, createdTime=2021-08-26, rootId=0, userName=sjzlzc016, userId=fc1826842253, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5a2f2098893d, moduleTitle=FIB-4指数：可预测慢乙肝患者抗病毒治疗后的肝癌风险, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=5a2f2098893d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1671787, encodeId=a35a16e17875d, content=<a href='/topic/show?id=0bcc2342943' target=_blank style='color:#2F92EE;'>#乙肝患者#</a>, objectTitle=Clin Gastroenterol Hepatol：抗病毒治疗时的HBeAg状态对慢性乙肝患者患肝癌风险的影响, objectType=article, longId=216950, objectId=dc6821695029, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dc6821695029, replyNumber=0, likeNumber=50, createdTime=2022-03-01, rootId=0, userName=sjzlzc016, userId=fc1826842253, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dc6821695029, moduleTitle=Clin Gastroenterol Hepatol：抗病毒治疗时的HBeAg状态对慢性乙肝患者患肝癌风险的影响, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=dc6821695029)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1671782, encodeId=9ff716e178200, content=<a href='/topic/show?id=0bcc2342943' target=_blank style='color:#2F92EE;'>#乙肝患者#</a>, objectTitle=Hepatology：他汀类药物可以降低乙肝患者肝细胞癌的风险, objectType=article, longId=201799, objectId=8b5a201e9922, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8b5a201e9922, replyNumber=0, likeNumber=57, createdTime=2021-09-08, rootId=0, userName=sjzlzc016, userId=fc1826842253, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8b5a201e9922, moduleTitle=Hepatology：他汀类药物可以降低乙肝患者肝细胞癌的风险, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=8b5a201e9922)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1671786, encodeId=c87816e178617, content=<a href='/topic/show?id=0bcc2342943' target=_blank style='color:#2F92EE;'>#乙肝患者#</a>, objectTitle=Liver Int：阿司匹林和他汀类药物与慢性乙肝患者的肝癌风险的相关性, objectType=article, longId=214099, objectId=26212140998b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=26212140998b, replyNumber=0, likeNumber=72, createdTime=2022-06-19, rootId=0, userName=sjzlzc016, userId=fc1826842253, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=26212140998b, moduleTitle=Liver Int：阿司匹林和他汀类药物与慢性乙肝患者的肝癌风险的相关性, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=26212140998b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1671783, encodeId=8d4b16e178368, content=<a href='/topic/show?id=0bcc2342943' target=_blank style='color:#2F92EE;'>#乙肝患者#</a>, objectTitle=J Gastroenterol：慢性乙肝患者体内残留的HBV DNA和pgRNA可使肝癌风险增加2-5倍！, objectType=article, longId=209221, objectId=7cda209221d4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7cda209221d4, replyNumber=0, likeNumber=55, createdTime=2021-03-30, rootId=0, userName=sjzlzc016, userId=fc1826842253, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7cda209221d4, moduleTitle=J Gastroenterol：慢性乙肝患者体内残留的HBV DNA和pgRNA可使肝癌风险增加2-5倍！, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=7cda209221d4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1671781, encodeId=9b6416e178100, content=<a href='/topic/show?id=0bcc2342943' target=_blank style='color:#2F92EE;'>#乙肝患者#</a>, objectTitle=J Hepatology：慢性乙肝患者的乙型肝炎核心特异性记忆B细胞的临床反应变化, objectType=article, longId=188594, objectId=2de618859436, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2de618859436, replyNumber=0, likeNumber=49, createdTime=2020-09-13, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2de618859436, moduleTitle=J Hepatology：慢性乙肝患者的乙型肝炎核心特异性记忆B细胞的临床反应变化, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=2de618859436)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1671780, encodeId=a3c016e178004, content=<a href='/topic/show?id=0bcc2342943' target=_blank style='color:#2F92EE;'>#乙肝患者#</a>, objectTitle=J Hepatology：乙肝患者在接受糖皮质激素治疗后发生乙型肝炎表面抗原血清逆转的风险增加, objectType=article, longId=186944, objectId=e9791869445c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e9791869445c, replyNumber=0, likeNumber=52, createdTime=2020-09-22, rootId=0, userName=sjzlzc016, userId=fc1826842253, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e9791869445c, moduleTitle=J Hepatology：乙肝患者在接受糖皮质激素治疗后发生乙型肝炎表面抗原血清逆转的风险增加, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=e9791869445c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1671779, encodeId=0d9d16e177970, content=<a href='/topic/show?id=0bcc2342943' target=_blank style='color:#2F92EE;'>#乙肝患者#</a>, objectTitle=Clin Chem：一种基于血清生物标记物的新型在线计算器用于检测乙肝患者的肝细胞癌, objectType=article, longId=185620, objectId=2f24185620dc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2f24185620dc, replyNumber=0, likeNumber=61, createdTime=2020-05-08, rootId=0, userName=sjzlzc016, userId=fc1826842253, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2f24185620dc, moduleTitle=Clin Chem：一种基于血清生物标记物的新型在线计算器用于检测乙肝患者的肝细胞癌, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=2f24185620dc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1671774, encodeId=ab3d16e17745f, content=<a href='/topic/show?id=0bcc2342943' target=_blank style='color:#2F92EE;'>#乙肝患者#</a>, objectTitle=adiology：2D US横波弹性成像在慢性乙肝患者肝硬化的价值, objectType=article, longId=160966, objectId=8d98160966e7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8d98160966e7, replyNumber=0, likeNumber=65, createdTime=2019-06-01, rootId=0, userName=sjzlzc016, userId=fc1826842253, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8d98160966e7, moduleTitle=adiology：2D US横波弹性成像在慢性乙肝患者肝硬化的价值, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=8d98160966e7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1671776, encodeId=bf0816e177678, content=<a href='/topic/show?id=0bcc2342943' target=_blank style='color:#2F92EE;'>#乙肝患者#</a>, objectTitle=J Hepatology：乙肝患者采用核苷（酸）类似物完全病毒抑制后可减少肝癌的发生, objectType=article, longId=162175, objectId=11381621e5e6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=11381621e5e6, replyNumber=0, likeNumber=49, createdTime=2019-07-28, rootId=0, userName=sjzlzc016, userId=fc1826842253, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=11381621e5e6, moduleTitle=J Hepatology：乙肝患者采用核苷（酸）类似物完全病毒抑制后可减少肝癌的发生, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=11381621e5e6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1671778, encodeId=4fec16e17788b, content=<a href='/topic/show?id=0bcc2342943' target=_blank style='color:#2F92EE;'>#乙肝患者#</a>, objectTitle=乙肝患者患肝癌几率有多高？, objectType=article, longId=166144, objectId=c04a16614457, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c04a16614457, replyNumber=0, likeNumber=75, createdTime=2019-05-22, rootId=0, userName=sjzlzc016, userId=fc1826842253, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c04a16614457, moduleTitle=乙肝患者患肝癌几率有多高？, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=c04a16614457)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1671777, encodeId=de6016e1777be, content=<a href='/topic/show?id=0bcc2342943' target=_blank style='color:#2F92EE;'>#乙肝患者#</a>, objectTitle=JAMA Intern Med：阿司匹林或可防肝癌！分析中国人群15年的数据发现，长期服用阿司匹林与慢性乙肝患者肝癌风险降低29%相关, objectType=article, longId=163056, objectId=c5cd1630565d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c5cd1630565d, replyNumber=0, likeNumber=56, createdTime=2019-10-08, rootId=0, userName=sjzlzc016, userId=fc1826842253, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c5cd1630565d, moduleTitle=JAMA Intern Med：阿司匹林或可防肝癌！分析中国人群15年的数据发现，长期服用阿司匹林与慢性乙肝患者肝癌风险降低29%相关, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=c5cd1630565d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1671772, encodeId=187e16e1772b7, content=<a href='/topic/show?id=0bcc2342943' target=_blank style='color:#2F92EE;'>#乙肝患者#</a>, objectTitle=明智抉择使初治慢性乙肝患者获理想效果, objectType=article, longId=149803, objectId=0dc41498033c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0dc41498033c, replyNumber=0, likeNumber=49, createdTime=2018-10-15, rootId=0, userName=sjzlzc016, userId=fc1826842253, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0dc41498033c, moduleTitle=明智抉择使初治慢性乙肝患者获理想效果, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=0dc41498033c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1671775, encodeId=ddf716e1775fa, content=<a href='/topic/show?id=0bcc2342943' target=_blank style='color:#2F92EE;'>#乙肝患者#</a>, objectTitle=JAMA Oncol：降低乙肝患者的肝癌风险替诺福韦or恩替卡韦更给力？, objectType=article, longId=161344, objectId=c9aa16134426, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c9aa16134426, replyNumber=0, likeNumber=72, createdTime=2020-02-11, rootId=0, userName=sjzlzc016, userId=fc1826842253, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c9aa16134426, moduleTitle=JAMA Oncol：降低乙肝患者的肝癌风险替诺福韦or恩替卡韦更给力？, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=c9aa16134426)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1671769, encodeId=130d16e1769dc, content=<a href='/topic/show?id=0bcc2342943' target=_blank style='color:#2F92EE;'>#乙肝患者#</a>, objectTitle=J Viral Hepat：慢乙肝患者HBeAg血清学转换后肝癌风险显著降低, objectType=article, longId=140814, objectId=73b414081494, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=73b414081494, replyNumber=0, likeNumber=62, createdTime=2019-01-04, rootId=0, userName=sjzlzc016, userId=fc1826842253, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=73b414081494, moduleTitle=J Viral Hepat：慢乙肝患者HBeAg血清学转换后肝癌风险显著降低, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=73b414081494)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1671770, encodeId=f98716e1770f5, content=<a href='/topic/show?id=0bcc2342943' target=_blank style='color:#2F92EE;'>#乙肝患者#</a>, objectTitle=【临床治愈，一生一试】乙肝患者争取治愈的希望能实现吗？, objectType=article, longId=141994, objectId=3b1d14199438, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3b1d14199438, replyNumber=0, likeNumber=54, createdTime=2019-06-05, rootId=0, userName=sjzlzc016, userId=fc1826842253, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3b1d14199438, moduleTitle=【临床治愈，一生一试】乙肝患者争取治愈的希望能实现吗？, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=3b1d14199438)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1671773, encodeId=356016e177334, content=<a href='/topic/show?id=0bcc2342943' target=_blank style='color:#2F92EE;'>#乙肝患者#</a>, objectTitle=【临床治愈，一生一试】PegIFNα-2a助乙肝患者获得最佳治疗目标, objectType=article, longId=155029, objectId=3e501550291a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3e501550291a, replyNumber=0, likeNumber=58, createdTime=2019-01-22, rootId=0, userName=sjzlzc016, userId=fc1826842253, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3e501550291a, moduleTitle=【临床治愈，一生一试】PegIFNα-2a助乙肝患者获得最佳治疗目标, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=3e501550291a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1671767, encodeId=f7d016e1767bc, content=<a href='/topic/show?id=0bcc2342943' target=_blank style='color:#2F92EE;'>#乙肝患者#</a>, objectTitle=J Infect Dis：慢乙肝患者替诺福韦或恩替卡韦停药复发的预测因素, objectType=article, longId=126198, objectId=12941261980e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=12941261980e, replyNumber=0, likeNumber=66, createdTime=2018-06-18, rootId=0, userName=sjzlzc016, userId=fc1826842253, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=12941261980e, moduleTitle=J Infect Dis：慢乙肝患者替诺福韦或恩替卡韦停药复发的预测因素, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=12941261980e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1671768, encodeId=65b616e1768b7, content=<a href='/topic/show?id=0bcc2342943' target=_blank style='color:#2F92EE;'>#乙肝患者#</a>, objectTitle=J Viral Hepat：采用常规临床指标预测慢性乙肝患者肝脏炎症程度, objectType=article, longId=137871, objectId=245e13e871c5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=245e13e871c5, replyNumber=0, likeNumber=64, createdTime=2018-10-17, rootId=0, userName=sjzlzc016, userId=fc1826842253, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=245e13e871c5, moduleTitle=J Viral Hepat：采用常规临床指标预测慢性乙肝患者肝脏炎症程度, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=245e13e871c5)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

乙肝患者

2020-05-29

sjzlzc016 (审核中...)

前往app查看评论内容

#乙肝患者#

Aliment Pharmacol Ther：中心性肥胖的慢性乙肝患者发展成肝癌的风险增加了两倍！

2021-10-25

sjzlzc016 (审核中...)

前往app查看评论内容

#乙肝患者#

FIB-4指数：可预测慢乙肝患者抗病毒治疗后的肝癌风险

2021-08-26

sjzlzc016 (审核中...)

前往app查看评论内容

#乙肝患者#

Clin Gastroenterol Hepatol：抗病毒治疗时的HBeAg状态对慢性乙肝患者患肝癌风险的影响

2022-03-01

sjzlzc016 (审核中...)

前往app查看评论内容

#乙肝患者#

Hepatology：他汀类药物可以降低乙肝患者肝细胞癌的风险

2021-09-08

sjzlzc016 (审核中...)

前往app查看评论内容

#乙肝患者#

Liver Int：阿司匹林和他汀类药物与慢性乙肝患者的肝癌风险的相关性

2022-06-19

sjzlzc016 (审核中...)

前往app查看评论内容

#乙肝患者#

J Gastroenterol：慢性乙肝患者体内残留的HBV DNA和pgRNA可使肝癌风险增加2-5倍！

2021-03-30

仁者大医 (审核中...)

前往app查看评论内容

#乙肝患者#

J Hepatology：慢性乙肝患者的乙型肝炎核心特异性记忆B细胞的临床反应变化

2020-09-13

sjzlzc016 (审核中...)

前往app查看评论内容

#乙肝患者#

J Hepatology：乙肝患者在接受糖皮质激素治疗后发生乙型肝炎表面抗原血清逆转的风险增加

2020-09-22

sjzlzc016 (审核中...)

前往app查看评论内容

#乙肝患者#

Clin Chem：一种基于血清生物标记物的新型在线计算器用于检测乙肝患者的肝细胞癌

2020-05-08

sjzlzc016 (审核中...)

前往app查看评论内容

#乙肝患者#

adiology：2D US横波弹性成像在慢性乙肝患者肝硬化的价值

2019-06-01

sjzlzc016 (审核中...)

前往app查看评论内容

#乙肝患者#

J Hepatology：乙肝患者采用核苷（酸）类似物完全病毒抑制后可减少肝癌的发生

2019-07-28

sjzlzc016 (审核中...)

前往app查看评论内容

#乙肝患者#

乙肝患者患肝癌几率有多高？

2019-05-22

sjzlzc016 (审核中...)

前往app查看评论内容

#乙肝患者#

JAMA Intern Med：阿司匹林或可防肝癌！分析中国人群15年的数据发现，长期服用阿司匹林与慢性乙肝患者肝癌风险降低29%相关

2019-10-08

sjzlzc016 (审核中...)

前往app查看评论内容

#乙肝患者#

明智抉择使初治慢性乙肝患者获理想效果

2018-10-15

sjzlzc016 (审核中...)

前往app查看评论内容

#乙肝患者#

JAMA Oncol：降低乙肝患者的肝癌风险替诺福韦or恩替卡韦更给力？

2020-02-11

sjzlzc016 (审核中...)

前往app查看评论内容

#乙肝患者#

J Viral Hepat：慢乙肝患者HBeAg血清学转换后肝癌风险显著降低

2019-01-04

sjzlzc016 (审核中...)

前往app查看评论内容

#乙肝患者#

【临床治愈，一生一试】乙肝患者争取治愈的希望能实现吗？

2019-06-05

sjzlzc016 (审核中...)

前往app查看评论内容

#乙肝患者#

【临床治愈，一生一试】PegIFNα-2a助乙肝患者获得最佳治疗目标

2019-01-22

sjzlzc016 (审核中...)

前往app查看评论内容

#乙肝患者#

J Infect Dis：慢乙肝患者替诺福韦或恩替卡韦停药复发的预测因素

2018-06-18

sjzlzc016 (审核中...)

前往app查看评论内容

#乙肝患者#

J Viral Hepat：采用常规临床指标预测慢性乙肝患者肝脏炎症程度

2018-10-17

科室
- - 订阅+
  - 更多科室
工具
服务